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Introduction: The aims of our study were to evaluate the impact of increased intra-abdominal pressure (IAP) on
central nervous system (CNS) cytokines (Interleukin 6 and tumor necrosis factor), lactate and perfusion pressures,
testing the hypothesis that intra-abdominal hypertension (IAH) may possibly lead to CNS ischemia.
Methods: Fifteen pigs were studied. Helium pneumoperitoneum was established and IAP was increased initially at
20 mmHg and subsequently at 45 mmHg, which was finally followed by abdominal desufflation. Interleukin 6 (IL-6),
tumor necrosis factor alpha (TNFa) and lactate were measured in the cerebrospinal fluid (CSF) and intracranial (ICP),
intraspinal (ISP), cerebral perfusion (CPP) and spinal perfusion (SPP) pressures recorded.
Results: Increased IAP (20 mmHg) was followed by a statistically significant increase in IL-6 (p = 0.028), lactate
(p = 0.017), ICP (p < 0.001) and ISP (p = 0.001) and a significant decrease in CPP (p = 0.013) and SPP (p = 0.002).
However, further increase of IAP (45 mmHg) was accompanied by an increase in mean arterial pressure due to
compensatory tachycardia, followed by an increase in CPP and SPP and a decrease of cytokines and lactate.
Conclusions: IAH resulted in a decrease of CPP and SPP lower than 60 mmHg and an increase of all ischemic
mediators, indicating CNS ischemia; on the other hand, restoration of perfusion pressures above this threshold
decreased all ischemic indicators, irrespective of the level of IAH.
Introduction
Intra-abdominal hypertension (IAH) and abdominal
compartment syndrome (ACS) are two clinical entities
constituting a continuum of pathophysiologic sequelae
ranging from mild elevations of intra-abdominal pres-
sure (IAP) to the devastating effects of organ hypoperfu-
sion and, uneventfully, to death. Although effects of
increased intra-abdominal pressure (IAP) on various
organs and systems have been reported over 150 years
ago, pathophysiologic implications have been rediscov-
ered and definitions and recommendations developed
the last few years [1-7].
Currently, the pathophysiological interaction of the
abdominal compartment with other compartments
(thoracic, cranial and extremities) has been extensively
studied, comprising the polycompartment syndrome, a
term coined by Malbrain M et al [5,8]. This holistic
view emphasizes the relationships developing directly
and indirectly between these body compartments, with
potential therapeutic implications in everyday practice.
An interesting part of this concept is the relationship
of IAH and the central nervous system (CNS) [9]. Sev-
eral experimental and clinical studies have described the
development of intracranial hypertension (ICP) and the
decrease in cerebral perfusion pressure (CPP) during
IAH [10-21]. These findings are based upon the modi-
fied Monroe-Kellie doctrine which recognizes four main
contents in the cranial space (osseous, vascular, cere-
brospinal fluid and parenchyma) the volume of each
reciprocally affecting each other. Moreover, Bloomfield
et al [13-15] suggested a mechanical effect of elevated
IAP on CNS; IAH raises intrathoracic pressure (ITP)
and jugular venous pressure, impeding cerebral venous
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any medium, provided the original work is properly cited.outflow. This results in an increase of the vascular com-
ponent and leads to increased ICP. Another mechanism
was proposed by Halverson et al [16], who demon-
strated experimentally that increased ICP during pneu-
moperitoneum was caused partially by decreased
absorption of the cerebrospinal fluid (CSF) in the region
of the lumbar cistern and the dural sleeves of the spinal
nerve roots. He suggested that this finding correlates
with the effect of increased inferior vena cava pressure
on the lumbar venous plexus, the outflow of which is
restricted, further impeding CSF absorption from the
arachnoid villi.
Taking into consideration the current knowledge con-
cerning the impact of IAH on the CNS we conducted
an experimental study in animals in order to investigate
whether increased ICP and intraspinal pressure (ISP), as
well as decreased CPP and spinal perfusion pressure
(SPP), might possibly lead further to CNS ischemia.
Development of ischemia was demonstrated by changes
in the CSF concentration of interleukin 6 (IL-6), tumor
necrosis factor alpha (TNFa) and lactate, which are con-
sidered to increase when CNS ischemia ensues [22-35].
Materials and methods
The study was performed in the experimental laboratory
‘Kostas Tountas’ of the Second Department of Surgery
at the Aretaieion University Hospital (Athens School of
Medicine, National and Kapodistrian University of
Athens), conforms to our institutional standards and is
under the appropriate license of the veterinary authori-
ties and in adherence to National and European regula-
tions for animal studies.
The protocol of our experimental study enrolled 15
female pigs (Sus scrofa domesticus) with a mean weight
of 30 kg (range, 25 to 35 kg). The first three animals
were a priori decided to be sacrificed in order to
develop and standardize our protocol. The correspond-
ing data were not complete so the animals were
excluded from our data. All animals were fasted for 12
hours before the experiment, with free access to water.
Anaesthesia
Sedation was achieved by intramuscular injection of
ketamine (4 to 6 mg/kg), atropine (0.5 mg/kg), and mid-
azolam (0.75 mg/kg). Then an intravenous line was
placed in the greater auricular vein and general anaes-
thesia was induced by thiopental 5 mg/kg, and fentanyl
2 μg/kg, and the animal was intubated. Basic monitoring
(electrocardiogram, oxygen saturation, non-invasive
pulse and arterial pressure monitoring) was applied.
Anaesthesia was maintained by isoflurane 0.5 to 1.5%,
vecuronium 0.1 mg/kg/h, fentanyl 2 μg/kg and midazo-
lam 5 mg/h. The animals were ventilated mechanically
(Drager Sulla 808V, type Ventilog-2, Drager, Berlin,
Germany) in a mixture of N2O/O2 at a FiO2 0.4 to 0.6,
respiratory rate varying from 16 to 30 breaths per min-
ute and tidal volumes ranging between 450 to 600 ml,
aiming at an end-tidal CO2 = 35 to 45 mmHg. End-tidal
concentration of N2O and isoflurane was monitored
continuously throughout the study in order to ensure
that depth of anaesthesia was maintained and boluses of
25 to 50 μg fentanyl and 5 mg midazolam were adminis-
tered according to needs.
Fluid infusion rate was standardized at 5 ml/kg/h dur-
ing pneumoperitoneum and was modified to 10 ml/kg/h
after abdominal desufflation.
Instrumentation
An 18 G catheter (Portex® minipack system, Smiths
Medical, Dublin, OH, USA) was placed after lumbar
puncture in the subarachnoid space and the correct pla-
cement was confirmed by the aspiration of CSF. The
catheter was connected through a non-compressible
tubing system to a standard transducer. Calibration was
performed using the right atrium as a zero point ensur-
ing that the operative table was in a neutral position.
ISP pressures were measured and CSF samples (0.5 to 1
ml each) were collected through this catheter.
A burr hole (2.7 mm) at a point 2 cm above the ani-
mal’s eyebrow served as a pathway for introducing intra-
cerebrally the Codman ICP monitoring system® (Johnson
&J o h n s o n ,R a y n h a m ,M A ,U S A ) ,w h i c hi n c l u d e sa
transducer (Codman Microsensor Transducer) that con-
nects to the pressure monitoring system (Codman ICP
express). Calibration was performed with the animal in
a neutral position, according to manufacturer’si n s t r u c -
tions. ICP pressures were measured through this system.
After surgical right neck dissection, the neurovascular
bundle was exposed and a 20 G catheter (Arterial Lea-
der-Cath 115.090, Vygon Corporation, Montgomeryville,
PA, USA) was introduced in the carotid artery for inva-
sive blood pressure monitoring and blood collection.
Then an introducer sheath 6 to 6.5 French was placed
in the ipsilateral internal jugular vein in order to pass
through it a Swan-Ganz catheter 5.5 Fr (Pediatric
Oximetry Thermodilution Catheter, model 631HF55,
Edwards Lifesciences, Irvine, CA, USA). The placement
of the catheter in the pulmonary artery was conformed
and calibrated.
A single lumen venous catheter (Leader-Cath 15 cm
119, Vygon Corporation, Montgomeryville, PA, USA)
was introduced into the inferior vena cava via the
femoral vein for collecting blood for cytokine measure-
ment and recording inferior vena cava pressure (IVCP).
Experimental phases
After instrumentation, animals were stabilized for 45 to
60 minutes (baseline phase T1). Then hemodynamic
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and blood samples collected. The next phase (T2)
started with the introduction of a Veress needle through
a small horizontal infra-umbilical incision into the peri-
toneal cavity. After connecting the Veress needle to the
laparoscopic insufflator, a preset IAP of 20 mmHg was
established mimicking intra-abdominal hypertension
grade II. Helium was used for insufflation instead of
CO2 in order to eliminate effec t so nb l o o dg a s e s[ 3 6 ] .
I A Po f2 0m m H gw a sm a i n t a i n e df o r4 5t o6 0m i n u t e s
and then pressures were recorded and samples collected
as in phase T1. Phase T3 included a further rise of IAP
by establishing a pneumoperitoneum of 45 mmHg for
a n o t h e r4 5t o6 0m i n u t e s ,m i m i c k i n gA C S ,a f t e rw h i c h
pressures were recorded and samples collected. Finally,
the abdomen was desufflated by opening the Veress
needle to the air (phase T4). After 45 to 60 minutes of
animal stabilization, pressures were recorded and
samples collected.
Induction of IAP in this animal study was clearly
mechanical, without developing conditions either of
capillary leakage which could interfere in interpretation
of cytokines and lactate measurements or intravascular
depletion (e.g. hemorrhage) interfering with hemody-
namic measurements. A net effect of mechanically
increased IAP on CNS pressures, cytokines and lactate
was attempted. We didn’t use a gradual increase of IAP,
but rather a first level of 20 mmHg, commonly seen in
clinical settings, and then an abrupt increase to 45
mmHg, in order to augment the impact of IAH on CNS
and draw safer conclusions for this relationship. Finally,
t h ei n c r e a s eo fI A Pi np h a s eT 3i sc o n s i d e r e da sA C S ,
according to definitions of the World Society of the
Abdominal Compartment Syndrome (WSACS)[1].
Calculation of preload assessment parameters
It is well established that increased IAP increases ITP
mechanically by the cephalad elevation of the dia-
phragm, simultaneously affecting preload intracardiac
filling pressures used traditionally, such as central
venous pressure (CVP), pulmonary arterial occlusion
pressure (PAOP), left atrial pressure and left ventricular
end-diastolic pressure. This phenomenon, called abdo-
mino-thoracic transmission, has been well studied in
several reports and resumed in an excellent editorial by
Malbrain et al [8] and is considered to be 50%. Cur-
rently, preload assessment during IAH and ACS is
accomplished by using volumetric indices, such as right
ventricular end-diastolic volume (RVEDV), global end-
diastolic volume (GEDV) and stroke volume variation
(SVV). However, when these cannot be used for practi-
cal reasons the calculation of transmural pressures can
be used instead:
Transmural PAOP = PAOP - IAP/2 and Transmural
CVP = CVP - IAP/2 [37].
Calculation of abdominal and CNS perfusion pressures
Abdominal (APP), cerebral (CPP) and spinal (SPP) per-
fusion pressures were calculated by subtracting IAP, ICP
and ISP from mean arterial pressure (MAP) respectively:
APP = MAP - IAP
CPP = MAP - ICP
SPP = MAP - ISP
Measurement of cytokines and lactate
Cytokines were measured by the ELISA technique,
using: a) the porcine ELISA test kits for IL-6 and TNFa
(Assay-design, Ann Arbor, MI, USA) for measurements
in CSF samples and b) the porcine ELISA test kits for
IL-6 and TNFa (Hyucult Biotech, Uden, Netherlands)
for the same purpose in blood samples. Lactate was
measured with a portable analyzer (Lactate Scout analy-
zer, Sports Resource Group, Inc., USA).
Study end-points
The main aim of this study was to demonstrate the
development of CNS ischemia under conditions of high
IAP. Two key elements were investigated as ischemic
predictors: decrease in CNS perfusion pressures and
increase of ischemia mediators (IL-6, TNFa and lactate).
Secondary end-points were the evaluation of the
impact of IAH on ICP and ISP, cardiovascular, respira-
tory and acid-base homeostasis.
Statistical analysis
Parametric and non-parametric tests were used accord-
ing to the distribution of measurements (tested by the
Anderson-Darling normality test). Thus, measurements
of all indicators in the blood and CSF are displayed as
median ± interquartile range (IQR), while measurements
of pressures are displayed as mean ± standard deviation,
respectively. Analysis of variance was applied using the
Friedman test. Wilcoxon paired-ranks test was used for
comparison of TNFa, IL-6 and lactate, while the paired
t-test was used for comparison of CNS pressures.
Relationships and covariance between variables were
investigated by Spearman correlation coefficient analysis.
The statistical software SPSS 11.0 (SPPS Inc., Chicago,
IL, USA) was used.
Results
With the exception of one animal (pig #5 died after
pneumoperitoneum was induced due to a massive pul-
monary embolism and was excluded from the study), 11
animals were included for the analysis of experimental
data, which are as follows.
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Interleukin 6
Abdominal insufflation to IAP 20 mmHg (T2) resulted
in a statistically significant increase of IL-6 in blood
(p = 0.043)a n dC S F( p = 0.028). Spearman correlation
coefficient analysis demonstrated a statistically signifi-
cant co-variance of changes of intraspinal pressure
(ΔISP) and CSF IL-6 (ΔIL-6), p = 0.042,d u r i n gt h i s
phase. Further increase of IAP to 45 mmHg was fol-
lowed by a statistically significant decrease in IL-6 in
CSF (p = 0.043), and, finally, abdominal desufflation was
followed by an increase of IL-6.
Tumor necrosis factor alpha
TNFa was increased in both blood and CSF. However, a
statistically significant (p = 0.012) increase of TNFa was
demonstrated only in blood during an increase of IAP
to 20 mmHg (T2). Further insufflation to 45 mmHg was
followed by a slight decrease of TNFa concentrations in
blood and CSF; finally, an increase of TNFa was
observed after abdominal desufflation.
Lactate (Table 1)
Lactate showed an increase in both blood and CSF after
increase of IAP to 20 mmHg, with a statistically signifi-
cant change (p = 0.017) demonstrated in the CSF. How-
ever, a further increase of IAP to 45 mmHg (T3)
resulted in a decrease of CSF lactate, which was slightly
increased after abdominal desufflation.
Central nervous system pressures (Table 2)
Unexpectedly, baseline ICP and ISP were above normal
levels (mean 18.7 and 13.2 mmHg, respectively). How-
ever, increase of IAP to 20 mmHg resulted in statistically
significant (p < 0.001) further increases of ICP and ISP,
whereas CPP (p = 0.013) and SPP (p = 0.002) decreased
significantly under the threshold for ischemia of 60
mmHg [24]. Paradoxically, further increase of IAP to 45
mmHg was followed by a minor increase of ICP and a
decrease of ISP, with a concomitant improvement of per-
fusion pressures above 60 mmHg. After abdominal desuf-
flation all measurements returned to baseline levels.




(IAP = 20 mmHg)
T3 (IAP = 45 mmHg) T4
(desufflation)
IL-6 Blood 635 (226) 755 (254.8) 584 (176) 676.5 (207.5)
p 0.043 (T1 vs. T2) 0.345 (T2 vs. T3) 1.00 (T3 vs. T4)
IL-6 CSF 611.5 (328.8) 917.5 (245.3) 822 (291) 825 (232)
p 0.028 (T1 vs. T2) 0.043 (T2 vs. T3) 0.715 (T3 vs. T4)
TNFa Blood 560 (798) 1070.5 (446.5) 710 (647) 854 (597)
p 0.012 (T1 vs. T2) 0.499 (T2 vs. T3) 0.612 (T3 vs. T4)
TNFa CSF 118.5 (160.3) 245 (331) 195 (396.5) 284.5 (497.5)
p 0.068 (T1 vs. T2) 0.463 (T2 vs. T3) 0.345 (T3 vs. T4)
Lac Blood 0.1 (1.85) 1.15 (1.3) 1.15 (1.375) 1.15 (1)
p 0.752 (T1 vs. T2) 0.496 (T2 vs. T3) 0.6 (T3 vs. T4)
Lac CSF 1.4 (1.7) 2.3 (1.3) 1.6 (2.8) 1.9 (1.6)
p 0.017 (T1 vs. T2) 0.237 (T2 vs. T3) 0.109 (T3 vs. T4)
CSF: cerebrospinal fluid; IL-6: interleukin 6, Lac: lactate, TNFa: tumor necrosis factor alpha. Data are displayed as median and interquartile range in parentheses.
IL-6 and TNFa are expressed as pg/ml and lactate as mmol/L. Statistical significances (p < 0.05) are marked in bold. IAP, intra-abdominal pressure.




(IAP = 20 mmHg)
T3
(IAP = 45 mmHg)
T4
(desufflation)
MAP 85.8 ± 9.62 79.8 ± 11.7 86.8 ± 15.73 84.6 ± 7.37
p 0.186 (T1 vs. T2) 0.297(T2 vs. T3) 0.625 (T3 vs. T4)
ICP 18.7 ± 7.57 25.4 ± 7.79 26.8 ± 9.17 15.3 ± 3.65
p <0.001(T1 vs. T2) 0.485 (T2 vs. T3) <0.001 (T3 vs. T4)
CPP 67.1 ± 13.81 54.4 ± 9.77 60 ± 16.54 69.3 ± 8.38
p 0.013 (T1 vs. T2) 0.392 (T2 vs. T3) 0.057 (T3 vs. T4)
ISP 13.2 ± 3.26 25.4 ± 8.36 22.3 ± 8 12.3 ± 3.86
p 0.001(T1 vs. T2) 0.375 (T2 vs. T3) 0.005 (T3 vs. T4)
SPP 72.6 ± 10.95 54.4 ± 10.6 64.5 ± 21.57 72.3 ± 7.42
p 0.002 (T1 vs. T2) 0.198 (T2 vs. T3) 0.235 (T3 vs. T4)
CPP is calculated as mean arterial pressure (MAP) minus intracranial pressure (ICP), while SPP as MAP minus intraspinal pressure (ISP). All pressures are displayed
as mean ± SD and expressed as mmHg. Statistical significances (p < 0.05) are marked with bold. IAP: intra-abdominal pressure.
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The transmission of the changes of IAP to another com-
partment as the cranial and spinal is assessed by the
index of transmission [8], which is expressed as percen-
tage and is calculated using the equation:
Index of Transmission  1 parameter IAP   /. 00
In order to compare the IAP in every phase we used
the measurements of IVCP, as follows:
T1 = 9.9 mmHg, T2 = 20.4 mmHg, T3 = 44.1 mmHg
and
T4 = 11.4 mmHg.
Thus, the index of transmission of IAP to CNS is the
following:
a. IAP (T1 ® T2): 63.8% (ICP), 116% (ISP),
b. IAP (T1 ® T3): 23.6% (ICP), 26.6% (ISP).
Cardiovascular system (Figures 1, 2, 3, 4 and 5)
Animals were considered normovolemic due to estimation
of the preload status with traditional CVP measurement
which was misleading. Calculation of the transmural intra-
cardiac filling pressures revealed that animals were hypo-
volemic with an associated tachycardia (Figure 1). Heart
rate initially decreased in phase T2, but was increased in
the two subsequent phases, with a parallel increase in
MAP and a decrease of APP (Figure 2). Cardiac output
and cardiac index were decreased in phase T3 and
restored to baseline levels after abdominal desufflation
(Figure 3). Systemic and pulmonary vascular resistances
increased significantly with IAH and decreased after
abdominal desufflation (Figure 4). IVCP reflected accu-
rately the changes in IAP (Figure 5).
Figure 1 Diagrammatic presentation of alterations of central
venous pressure (CVP) and pulmonary artery occlusion
pressure (PAOP). These changes occurred during the four
experimental phases (1: baseline, 2: IAP 20 mmHg, 3: IAP 45 mmHg
and 4: abdominal desufflation). Traditional measurements are
depicted by the solid line and transmural measurements by the
intermitted line.
Figure 2 Diagrammatic presentation of alterations of heart
rate (HR), mean arterial pressure (MAP) and abdominal
perfusion pressure (APP). These changes occurred during the four
experimental phases (1: baseline, 2: IAP 20 mmHg, 3: IAP 45 mmHg
and 4: abdominal desufflation).
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5, 6, 7)
IAH increased peak inspiratory pressure (PIP) in both
phases T2 and T3, declining after abdominal desuffla-
tion (Figure 5). In contrary, pH was decreased during
T2 and T3 and increased to baseline levels after removal
of the pneumoperitoneum (Figure 6). This change was
associated with an increase in pCO2 in the same phases,
which returned to baseline levels after desufflation. A
concomitant decrease in bicarbonate and base deficit
were observed, without, in fact, compensating the acute
respiratory acidosis (Figure 7). Finally, end-tidal carbon
dioxide (EtCO2) varied between pre-established limits
(35 to 45 mmHg) (Figure 7).
Discussion
In the present study, we analyzed the changes in CNS
perfusion pressures in relation to changes in CSF pro-
inflammatory cytokines (IL-6 and TNFa) and a metabo-
lite (lactate), during a controlled increase in IAP, in order
to determine whether CNS ischemia ensued. The main
findings of this experimental study are as follows: first, all
ischemic mediators (IL-6, TNFa and lactate) were
significantly increased when both perfusion pressures
(CPP and SPP) decreased less than 60 mmHg; second,
IL-6 was considered the most sensitive marker of ISP
rise; third, all ischemic mediators decreased when perfu-
sion pressures increased more than 60 mmHg, irrespec-
tive of the level of IAH and, finally, IAH had a negative
impact on cardio-respiratory function and acid-base
homeostasis.
According to the guidelines for the management of
severe traumatic brain injury of the Brain Trauma
Foundation [38], hypotension (systolic blood pressure
<90 mmHg), hypoxia (PaO2 <60 mmHg or O2 satura-
tion <90%), ICP >20 mmHg and CPP < 60 mmHg
should be avoided, in order to prevent cerebral ische-
mia. In our experimental study hypotension and
hypoxia were not observed. However, CNS perfusion
pressures (CPP and SPP) were both decreased lower
than the ischemia threshold of 60 mmHg when the IAP
was increased to 20 mmHg (phase T2). This decrease
was concomitantly associated with a significant increase
of ischemic mediators. Both changes indicate that CNS
ischemia ensued. The significant statistical correlation
of the changes of ISP and IL-6 measured in the CSF
Figure 3 Diagrammatic presentation of alterations of cardiac
index (CI) and cardiac output (CO). These changes occurred
during the four experimental phases (1: baseline, 2: IAP 20 mmHg,
3: IAP 45 mmHg and 4: abdominal desufflation).
Figure 4 Diagrammatic presentation of alterations of systemic
(SVR) and pulmonary (PVR) vascular resistances. These changes
occurred during the four experimental phases (1: baseline, 2: IAP 20
mmHg, 3: IAP 45 mmHg and 4: abdominal desufflation).
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marker of ISP changes than the other two mediators.
A limitation of this study is that modern technology was
not used for practical reasons. Modern technology uses
multiparametric neuromonitoring to support brain trauma
victims in current clinical practice by inserting intracra-
nially probes that can measure directly intracranial pres-
sure, brain tissue oxygenation, vascular flow and cerebral
metabolism [39-43]. Despite the absence of more direct
methods of CNS ischemia demonstration, the suggestion
that ischemia ensued in phase T2 (IAP 20 mmHg) was
reinforced by the observation in phase T3 (IAP 45
mmHg): CNS perfusion pressures increased more than the
ischemia threshold of 60 mmHg, which was followed by a
decrease in all ischemia indicators, irrespective of the pre-
sence of even higher IAP. Improvement of CNS perfusion
was a result of an increase of MAP, which in turn resulted
from an augmented compensatory tachycardia, due to
further decrease in preload parameters. An alternative
explanation for increased MAP is provided by Citerio G et
al [20] who state that increased intrathoracic pressure
facilitates systolic ejection. Another possible explanation of
this phenomenon could be that the first period of elevated
CNS pressure and ischemia (phase T2) acted as a precon-
ditioning period alleviating further ischemic changes of
the brain during phase T3 [44-48].
Another interesting point is that a further increase of
IAP to 45 mmHg was not followed by a similar dra-
matic increase of ICP and ISP. On the contrary, ISP
decreased and ICP was only slightly increased. This phe-
nomenon is explained by the reduction of the CSF
volume by sampling: approximately 0.5 to 1 ml of CSF
aspirated in every experimental phase, multiplied by
three (T1 to T3) is 1.5 to 4.5 ml of CSF withdrawn.
A clinical paradigm of this effect is the prevention of
paraplegia with CSF drainage during surgical repair of
extended thoracoabdominal aneurysms [49,50], in order
to alleviate intraspinal hypertension.
Abdominal desufflation (phase T4) was followed by
restoration of CNS pressures to baseline levels and a
further increase of all indicators (IL-6, TNFa and
Figure 5 Diagrammatic presentation of alterations of inferior
vena cava pressure (IVCP) and peak inspiratory pressure (PIP).
These changes occurred during the four experimental phases (1:
baseline, 2: IAP 20 mmHg, 3: IAP 45 mmHg and 4: abdominal
desufflation).
Figure 6 Diagrammatic presentation of alterations of pH, pCO2
and pO2. These changes occurred during the four experimental
phases (1: baseline, 2: IAP 20 mmHg, 3: IAP 45 mmHg and 4:
abdominal desufflation).
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and CNS reperfusion.
The negative impact of IAH on the cardiovascular sys-
tem (decreased preload, decreased contractility,
increased afterload), airway pressure (increased PIP) and
acid-base homeostasis (acute respiratory acidosis) is in
accordance with the currently described and accepted
pathophysiological implications of the syndrome
[3-5,7,37]. Abdominal desufflation was followed by nor-
malization of all these parameters.
However, this study had many inherent limitations. The
small sample size, the absence of controls and any inter-
vention, and the high IAP used in phase T3 (45 mmHg,
not extrapolated in the clinical setting) are inherent para-
meters confined ap r i o r iby the experimental protocol.
Other important limitations which interfered with data
measurements and interpretation are the following:
Hypovolemia
During this experimental study traditional measure-
ments of CVP and PAOP were used for the assessment
of the preload status. According to them, all animals
were normovolemic. However, after collecting data and
calculating the transmural pressures, we realized that all
animals were actually hypovolemic.
a) Transmural CVP (mmHg): 1.9 (T1)/-3.3 (T2)/-16.6
(T3)/-0.5 (T4)
b) Transmural PAOP (mmHg): 4.85 (T1)/-1.6 (T2)/-
14.4 (T3)/3 (T4).
This observation (hypovolemia) explains the unex-
pected baseline tachycardia (which was attributed initi-
ally to not adequate depth of anaesthesia or
administration of atropine, and so on). Moreover, this is
a condition that augments the impact of IAH on the
cardiovascular system.
High baseline IAP
Changes in IVCP are known to reflect accurately
changes in IAP [3]. This was actually confirmed in our
study. However, we observed that baseline IAP was
increased at the beginning (9.9 mmHg) and at the end
of the experiment (11.4 mmHg). An explanation of this
is provided by the mechanism of action of fentanyl,
administered for maintenance of anaesthesia: fentanyl
induces muscle contraction and rigidity of the chest and
abdominal wall, as well as the extremities above a criti-
cal concentration [51-55].
High baseline ICP
Moderately increased baseline IAP was responsible for a
similar moderate increase of ICP, according to the
mechanisms that have been proposed by Bloomfield and
Halverson [13-15].
The two last limitations (high IAP and ICP) resemble
the clinical scenario of development of IAH in patients
with the presence of already increased ICP (due to
trauma, vascular accidents or metabolic causes).
Conclusions
IAH significantly reduces cerebral and spinal perfusion
pressures, concomitantly increasing IL-6, lactate and
TNFa in CSF, suggesting the development of CNS ische-
mia. However, this effect was transient and reversible
when perfusion pressures were restored to a level above
60 mmHg, irrespective of the level of IAH.
Key messages
￿ Intra-abdominal hypertension led to increases of
ICP and ISP.
￿ Increased ICP and ISP resulted in decreases of
CPP and SPP, respectively.
Figure 7 Diagrammatic presentation of alterations of
bicarbonate (HCO3
-), base deficit and end-tidal carbon dioxide
(EtCO2). These changes occurred during the four experimental
phases (1: baseline, 2: IAP 20 mmHg, 3: IAP 45 mmHg and 4:
abdominal desufflation).
Marinis et al. Critical Care 2010, 14:R31
http://ccforum.com/content/14/2/R31
Page 8 of 10￿ When CPP and SPP decreased below 60 mmHg an
increase in IL-6, TNFa and lactate in the CSF sug-
gested the development of CNS ischemia
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